IDT Corp appoints William Conkling to Board as Audit Committee Chair following director resignation

Filed June 10, 2026 · Period ending June 9, 2026 · ~1 min read

Key Changes

• medium

  William Conkling appointed to Board on June 9, 2026, designated as independent director and named Audit Committee Chairman and Financial Expert, filling vacancy from Katsof's departure.

  Item 5.02 verify on EDGAR →
• medium

  Director Irwin Katsof resigned from Board and all committees on June 9, 2026. Filing explicitly states resignation was not due to any disagreement with Company operations, policies, or practices.

  Item 5.02 verify on EDGAR →
• low

  Conkling will also serve on Compensation and Corporate Governance Committees. He brings pharmaceutical industry experience as current CCO of Protara Therapeutics and former CEO of Rafael Holdings.

  Item 5.02 verify on EDGAR →